This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Business - MarketWatch - November 14

Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climate

Biotech-stock investing has one tough test for success — and it’s about to get easier

Business - MarketWatch - Yesterday

Bipolar disorder: how lithium as a treatment fell out of favour

As UK diagnoses have doubled, prescriptions of the treatment have halved. While experts feud over its use, many patients feel it is an effective way of managing their condition. Occupational stress ...

World - The Guardian - November 9

Vietnam waits for major upgrade to its $200 billion stock market

Vietnam's chip capabilities have it competing against near neighbor Malaysia, attracting global semiconductor firms.

Business - CNBC - October 28

Icahn Enterprises’ stock slides 14% as majority-owned CVR Energy suspends its dividend

Icahn Enterprises LP’s stock fell 4% early Tuesday, after CVR Energy Inc., in which it owns a 66% stake, said it would suspend its third-quarter dividend, as unplanned outages and a weak macro ...

Business - MarketWatch - October 29

What to know about a tropical depression that could develop into a late-season storm

Meteorologist Stephanie Abrams with The Weather Channel gives an update on Tropical Depression 19 in the Caribbean, which could develop into a late-season storm that impacts Florida.

The First Crispr Treatment Is Making Its Way to Patients

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.

Tech - Wired - 6 days ago

Disney is doubling its fleet of cruise ships. What that says about the company's strategy

As the future clouds for Walt Disney Co.'s lucrative theme parks business, one bright spot continues to be its cruise line.

Entertainment - Los Angeles Times - October 23

Biogen’s stock hit by soft sales of Alzheimer’s treatment

“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.

Business - MarketWatch - October 30

Russia Could Expand Its Assistance to Houthis, U.S. Says

The group’s attacks in the Red Sea have driven up shipping costs and forced the United States and its allies to increase their naval presence in the region.

World - The New York Times - October 25

These stocks could benefit from Trump’s election victory, B. Riley says

Trump’s victory could benefit a host of stocks from sectors such as coal mining, fintech, cryptocurrency and for-profit education, says B. Riley Securities.

Business - MarketWatch - November 6

Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin

Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin.

Business - MarketWatch - November 7

Catherine joins royals at first major event since finishing treatment

The Princess of Wales has joined the rest of the Royal Family at the Festival of Remembrance in London's Royal Albert Hall.

Princess Kate makes first major public appearance since cancer treatment

Catherine Kate, the Princess of Wales, attended a memorial service for Britain's military veterans over the weekend. This was her first high-profile event since ending cancer treatment earlier this ...

Lucy had postnatal depression and ended her life - could more have been done?

The family of a woman who ended her life while suffering postnatal depression say she was let down.

American to pay $50 million fine for its treatment of disabled passengers

Airlines must be accountable for their treatment of passengers with disabilities, Transportation Secretary Pete Buttigieg said.

Super Micro still can’t say when it will file annual report, and its stock drops

Server maker doesn’t expect its accounting issues to impact its ability to serve customers

Business - MarketWatch - November 6

Arm says it’s fueling many AI needs, but its stock shrugs off an earnings beat

The chip designer beat expectations for both its revenue segments.

Business - MarketWatch - November 7

Starbucks turnaround plan has ‘merit’ but its unknown cost makes the stock a ‘sell,’ analyst says

Redburn Atlantic’s Edward Lewis downgrades coffee-shop giant after new Chief Executive Brian Niccol unveils his “Back to Starbucks” plan.

Business - MarketWatch - November 13

Tesla should sell its stock after the big post-election run up, analyst says

Tesla should take advantage of its stock’s post-election surge to raise capital by selling shares, a Jefferies analyst says.

Business - MarketWatch - 6 days ago

‘Exciting’ new lupus treatment could end need for lifelong medication

CAR T-cell genetic therapy, typically used in cancer patients, could lead to cure for the disease, says expert. Doctors are hailing a “groundbreaking” new treatment for lupus that genetically ...

World - The Guardian - November 8

Nvidia doubles down on India with Hindi language model and major partnerships

Nvidia on Thursday announced a slew of partnerships with major Indian firms and launched a Hindi language model.

Business - CNBC - October 24

'I've lost major organs to endometriosis' - NHS gynaecology waiting lists double

Around 630,000 women are waiting for gynaecology appointments as waiting lists double in four years.

FirstFT: Japan plunges into political chaos

Also in today’s newsletter, oil price falls and Franklin Templeton hit by record outflows

World - Financial Times - October 28

Starbucks’ new CEO has diagnosed its problems. Analysts say the solutions could get expensive.

Starbucks CEO Brian Niccol has laid out a bold turnaround plan for the coffee chain, with plans to tighten up service and redesign stores. But analysts are proceeding with caution.

Business - MarketWatch - November 1

‘FOMO’ could help drive stocks higher after the election, one top Goldman Sachs strategist says

The upcoming U.S. election has helped inspire a sense of foreboding on Wall Street, judging by the still-elevated level of the Cboe Volatility Index, otherwise known as the VIX or the stock ...

Business - MarketWatch - October 28

Morgan Stanley finally turns bullish on U.S. stocks as it says the S&P 500 could jump as high as 7,400

Better late than never? Morgan Stanley says it’s now overweight U.S. stocks.

Business - MarketWatch - 3 days ago

'Sorry' water boss has plan to end sewage spillages

Water UK chief apologises for the industry's performance as the sector faces a "root and branch" review.

Rick Scott says he thinks DeSantis will pick Lara Trump to succeed Rubio

Sen. Rick Scott (R-Fla.) said he thinks the state’s Gov. Ron DeSantis (R) will pick Lara Trump to replace Sen. Marco Rubio (R-Fla.), who President-elect Trump tapped to serve as Secretary of State. ...

Politics - The Hill - Yesterday

HRT should be first-line menopause treatment, NICE says

Information on the menopause drugs' benefits and risks have been included in updated guidance.

Peloton’s stock is double-upgraded as new CEO helps swing BofA to bullish

Peloton’s stock rallied after the company’s biggest Wall Street bear turned bullish following the announcement of a new CEO and an upbeat earnings report.

Business - MarketWatch - November 4

U.S. stocks staged an epic rally after Trump won the election. What history says could happen before year-end.

Historically, stocks have tended to rise in the postelection period — and market analysts say they still have the potential to keep climbing through the rest of the year.

Business - MarketWatch - November 7

Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 24%

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile disfunction and men's hair loss.

Business - CNBC - 6 days ago

Latest in This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho